Home LiteratureArticle Details
PMID: 8319332 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Relation between upper limit of vulnerability and defibrillation threshold in humans.

Circulation ·Vol. 88 ·No. 1 ·1993-07-00 ·Pages 186-92

Chen PS, Feld GK, Kriett JM, Mower MM, Tarazi RY, Fleck RP, Swerdlow CD, Gang ES, Kass RM

Abstract

In the canine model, an upper limit of shock strength exists that can induce ventricular fibrillation during the vulnerable period of the cardiac cycle. This shock strength (the upper limit of vulnerability) closely correlates with the defibrillation threshold and supports the "upper limit of vulnerability" hypothesis of defibrillation. It is not known whether an upper limit of vulnerability exists in humans or whether this limit correlates with the defibrillation threshold. In 13 patients undergoing implantable cardioverter-defibrillator implantation, the shock strengths associated with a 50% probability of reaching the upper limit of vulnerability (ULV50) and a 50% probability of reaching the defibrillation threshold (DFT50) were determined by the up-down algorithm. The ULV50 was determined only for the mid-upslope of the positive T waves and for the mid-downslope of the negative T waves. No major complications occurred during surgery. An upper limit of vulnerability was demonstrated in each patient. The ULV50 was 300 +/- 138 V or 6.8 +/- 5.8 J, which was significantly lower than the DFT50 of 347 +/- 167 V (p = 0.038) or 9.1 +/- 7.3 J (p = 0.013). The correlation between the ULV50 and the DFT50 was significant (r = 0.90, p < 0.001 for voltage; r = 0.93, p < 0.001 for energy). An upper limit of vulnerability is present in humans. There is a significant correlation between the ULV50 and the DFT50, and the ULV50 is significantly lower than the DFT50.

MeSH Terms
Algorithms Cardiac Pacing, Artificial Death, Sudden, Cardiac/prevention & control Defibrillators, Implantable Electric Countershock Heart Conduction System/physiopathology Humans Male Middle Aged Tachycardia, Ventricular/therapy Ventricular Fibrillation/etiology,physiopathology,prevention & control
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Chen P S
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Feld G K
Kriett J M
Mower M M
Tarazi R Y
Fleck R P
Swerdlow C D
Gang E S
Kass R M
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
0009-7322
Published
1993-07-00
Pages
186-92
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Grants
NHLBI NIH HHS · HL-50259-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]